Impact of Oral Abrocitinib Monotherapy on Patient-Reported Symptoms and Quality of Life in Adolescents and Adults with Moderate-to-Severe Atopic Dermatitis: A Pooled Analysis of Patient-Reported Outcomes.

Jonathan I SilverbergJacob P ThyssenEric L SimpsonGil YosipovitchSonja StänderHernan ValdezRicardo RojoPinaki BiswasDaniela E MyersClaire FeeneyMarco daCosta DiBonaventura

Published in: American journal of clinical dermatology (2021)

NCT02780167 (registered 23 May, 2016), NCT03349060 (registered 21 November, 2017), NCT03575871 (registered 3 July, 2018).

Keyphrases

patient reported outcomes
patient reported
atopic dermatitis
young adults
physical activity
high intensity
early onset
open label
randomized controlled trial
clinical trial
depressive symptoms
phase iii